Which has the lower trailing P/E, CTAS or EMR?

EMR has the lower trailing P/E: CTAS trades at 40.62 and EMR at 31.92. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, CTAS or EMR?

Over the past five years, CTAS grew revenue faster — CTAS at a 9.62% CAGR versus EMR at 0.87%.

Does CTAS or EMR pay a bigger dividend?

CTAS yields 0.89% and EMR yields 1.46% based on trailing dividends and the latest price.

Is CTAS or EMR more profitable?

CTAS runs the higher net margin — CTAS at 17.75% versus EMR at 13.83%.

How have CTAS and EMR total returns compared?

Over the past 10 years, CTAS delivered 22.94% and EMR delivered 14.33% annualized total return. Past performance doesn't predict future results.

Cintas Corporation (CTAS) vs Emerson Electric Co. (EMR)

A side-by-side comparison of Cintas Corporation and Emerson Electric Co. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of September 13, 2026. Differences are shown without an overall score or investment verdict.

CTAS

Cintas Corporation

$79.82B

$199.46IndustrialsDelayed quote: Sep 16, 2026, 4:00 PM EDT

EMR

Emerson Electric Co.

$81.70B

$145.86IndustrialsDelayed quote: Sep 16, 2026, 3:59 PM EDT

Total return — CTAS vs EMR

growth of $100 · dividends reinvested · last 10y

CTAS +688.8% (+22.9%/yr)EMR +279.2% (+14.3%/yr)CTAS compounded faster over this window

CTAS EMR

CTAS vs EMR: by the numbers

•EMR is the larger company ($81.70B vs $79.82B market cap).
•EMR trades at the lower trailing earnings multiple (31.92 vs 40.62 P/E), one valuation lens rather than an overall verdict.
•CTAS converts more revenue to profit (17.75% vs 13.83% net margin).
•CTAS grew revenue faster over the past five years (9.62% vs 0.87% CAGR).
•EMR pays the higher dividend yield (1.46% vs 0.89%).

Metrics side by side

Valuation

Metric	CTAS	EMR
P/E ratio	40.62	31.92
Forward P/E	36.25	22.24
P/S ratio	7.09	4.38
P/B ratio	15.53	4.01
EV / EBITDA	26.36	18.45
FCF yield	2.36%	4.24%

Profitability

Metric	CTAS	EMR
Gross margin	50.67%	53.16%
Operating margin	23.14%	20.11%
Net margin	17.75%	13.83%
ROE	38.91%	12.65%
ROIC	23.53%	7.93%

Dividends

Metric	CTAS	EMR
Dividend yield	0.89%	1.46%
Payout ratio	36.66%	48.58%

Growth (annualized)

Metric	CTAS	EMR
Revenue CAGR (5Y)	9.62%	0.87%
EPS CAGR (5Y)	13.58%	4.54%
FCF CAGR (5Y)	9.10%	0.41%
Total return CAGR (5Y)	15.89%	10.92%

Frequently asked

Which has the lower trailing P/E, CTAS or EMR?: EMR has the lower trailing P/E: CTAS trades at 40.62 and EMR at 31.92. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, CTAS or EMR?: Over the past five years, CTAS grew revenue faster — CTAS at a 9.62% CAGR versus EMR at 0.87%.
Does CTAS or EMR pay a bigger dividend?: CTAS yields 0.89% and EMR yields 1.46% based on trailing dividends and the latest price.
Is CTAS or EMR more profitable?: CTAS runs the higher net margin — CTAS at 17.75% versus EMR at 13.83%.
How have CTAS and EMR total returns compared?: Over the past 10 years, CTAS delivered 22.94% and EMR delivered 14.33% annualized total return. Past performance doesn't predict future results.

Go deeper

Full CTAS analysis Full EMR analysis Interactive comparison tool

Dig into the metrics

Cintas P/E ratio Emerson Electric P/E ratio Cintas dividend yield Emerson Electric dividend yield Cintas ROE Emerson Electric ROE Cintas operating margin Emerson Electric operating margin Cintas revenue growth Emerson Electric revenue growth Cintas free cash flow Emerson Electric free cash flow

Cintas & Emerson Electric appear in these rankings

25+ Year Dividend Growers Highest ROE Stocks Highest ROIC Stocks Highest FCF Yield Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified September 13, 2026.